Fall in funding set to slow life sciences occupier activity

Life sciences occupiers are taking longer to execute expansion plans amid a shift in the types of funding they receive, according to research by Carter Jonas. Although funding secured by businesses in the sector reached $5.9bn (£4.8bn) as of 30